Statistics for BioCryst Pharmaceuticals (id:7696 BCRX)
Valuation metrics
Market cap
1.46B
Enterprise value
1.97B
Trailing P/E (ttm)
-6.44
Forward P/E
-176.50
PEG ratio
-176.50
Price/Sales (ttm)
3.54
Price/Book (mrq)
-3.36
Enterprise Value/Revenue
4.77
Enterprise Value/EBITDA
-61.62
Overview
Shares outstanding
207.13M
Float
192.65M
Shares short
20.83M
% Held by insiders
0.01%
% Held by institutions
0.86%
Average volume (10 days)
2.23M
Average volume (90 days)
Price summary
52-Week low
4.03
52-Week high
8.88
52-Week change
30.00%
Beta
1.89
50-Day moving average
7.70
200-Day moving average
6.53
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
June 11th, 2014
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
-30.01%
Operating margin
6.57%
Operational effectiveness
Return on assets
-4.25%
Return on equity
49.73%
Income statement
Revenue (ttm)
2.01
Revenue per share (ttm)
2.01
Quarterly revenue growth (yoy)
Gross profit (ttm)
326.75M
EBITDA
-31,941,000.00
Net income to common (ttm)
-123,817,000.00
Diluted EPS (ttm)
-0.61
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
330.01M
Total cash per share (mrq)
1.59
Total debt (mrq)
842.14M
Total Debt/Equity (mrq)
-1.80
Current ratio (mrq)
278.10%
Book value per share (mrq)
-2.26
Cash flow
Cash flow statement
-55,725,000.00
Levered free cash flow (LFCF)
15.87M